Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 430

1.

Osthole ameliorates insulin resistance by increment of adiponectin release in high-fat and high-sucrose-induced fatty liver rats.

Qi Z, Xue J, Zhang Y, Wang H, Xie M.

Planta Med. 2011 Feb;77(3):231-5. doi: 10.1055/s-0030-1250268. Epub 2010 Aug 17.

PMID:
20717873
2.
3.

Pan-PPAR agonist beneficial effects in overweight mice fed a high-fat high-sucrose diet.

Fernandes-Santos C, Carneiro RE, de Souza Mendonca L, Aguila MB, Mandarim-de-Lacerda CA.

Nutrition. 2009 Jul-Aug;25(7-8):818-27. doi: 10.1016/j.nut.2008.12.010. Epub 2009 Mar 5.

PMID:
19268533
4.

Therapeutic effect of osthole on hyperlipidemic fatty liver in rats.

Zhang Y, Xie ML, Zhu LJ, Gu ZL.

Acta Pharmacol Sin. 2007 Mar;28(3):398-403.

5.

[Therapeutic effects of insulin-sensitizing drugs on nonalcoholic fatty liver disease: experiment with rats].

Zhang DM, Zhang GY, Wang T, Zhong HJ, Chen WK.

Zhonghua Yi Xue Za Zhi. 2006 May 16;86(18):1279-83. Chinese.

PMID:
16796890
6.

[Effects of total glucosides of paeony on enhancing insulin sensitivity and antagonizing nonalcoholic fatty liver in rats].

Zheng LY, Pan JQ, Lv JH.

Zhongguo Zhong Yao Za Zhi. 2008 Oct;33(20):2385-90. Chinese.

PMID:
19157135
7.

Involvement of hepatic peroxisome proliferator-activated receptor α/γ in the therapeutic effect of osthole on high-fat and high-sucrose-induced steatohepatitis in rats.

Zhao X, Xue J, Wang XL, Zhang Y, Deng M, Xie ML.

Int Immunopharmacol. 2014 Sep;22(1):176-81. doi: 10.1016/j.intimp.2014.06.032. Epub 2014 Jun 30.

PMID:
24993341
8.

[Study on therapeutic effects of metformin on rat fatty livers induced by high fat feeding].

Gao ZQ, Lu FE, Dong H, Xu LJ, Wang KF, Zhou X.

Zhonghua Gan Zang Bing Za Zhi. 2005 Feb;13(2):101-4. Chinese.

PMID:
15727694
9.

Osthole improves glucose and lipid metabolism via modulation of PPARα/γ-mediated target gene expression in liver, adipose tissue, and skeletal muscle in fatty liver rats.

Qi ZG, Zhao X, Zhong W, Xie ML.

Pharm Biol. 2016;54(5):882-8. doi: 10.3109/13880209.2015.1089295. Epub 2015 Oct 10.

PMID:
26455539
10.

Research on the protection effect of pioglitazone for non-alcoholic fatty liver disease (NAFLD) in rats.

Xu P, Zhang XG, Li YM, Yu CH, Xu L, Xu GY.

J Zhejiang Univ Sci B. 2006 Aug;7(8):627-33.

11.

[Effects of rosiglitazone and metformin on insulin resistance in high-fat diet rats].

Chen XP, Yang WY, Bu S, Xiao JZ, Liu XL, Wang N, Zhao WH.

Zhonghua Nei Ke Za Zhi. 2004 Apr;43(4):280-3. Chinese.

PMID:
15130413
12.

The ameliorating effect of rosiglitazone on experimental nonalcoholic steatohepatitis is associated with regulating adiponectin receptor expression in rats.

Liu S, Wu HJ, Zhang ZQ, Chen Q, Liu B, Wu JP, Zhu L.

Eur J Pharmacol. 2011 Jan 10;650(1):384-9. doi: 10.1016/j.ejphar.2010.09.082. Epub 2010 Oct 20.

PMID:
20965162
13.

Inhibitory effect of osthole on alcohol-induced fatty liver in mice.

Sun F, Xie ML, Zhu LJ, Xue J, Gu ZL.

Dig Liver Dis. 2009 Feb;41(2):127-33. doi: 10.1016/j.dld.2008.01.011. Epub 2008 Mar 12.

PMID:
18339590
14.

Pioglitazone can ameliorate insulin resistance in low-dose streptozotocin and high sucrose-fat diet induced obese rats.

Ding SY, Shen ZF, Chen YT, Sun SJ, Liu Q, Xie MZ.

Acta Pharmacol Sin. 2005 May;26(5):575-80.

15.

Fenretinide ameliorates insulin resistance and fatty liver in obese mice.

Koh IU, Jun HS, Choi JS, Lim JH, Kim WH, Yoon JB, Song J.

Biol Pharm Bull. 2012;35(3):369-75.

16.

[Effect of peroxisome proliferator-activated receptor-alpha agonist on adipokines expression in rats fed with high-fat diet].

Li Y, Huang B, Cheng H, Liang Z, Liu SY.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2006 Dec;28(6):761-5. Chinese.

17.

Synergistic improvement in insulin resistance with a combination of fenofibrate and rosiglitazone in obese type 2 diabetic mice.

Choi WS, Lee JJ, Kim Y, Kim IS, Zhang WY, Myung CS.

Arch Pharm Res. 2011 Apr;34(4):615-24. doi: 10.1007/s12272-011-0412-9. Epub 2011 May 5.

PMID:
21544727
18.

High-fat- and lipid-induced insulin resistance in rats: the comparison of glucose metabolism, plasma resistin and adiponectin levels.

Li L, Yang G, Li Q, Tang Y, Li K.

Ann Nutr Metab. 2006;50(6):499-505. Epub 2006 Dec 21.

PMID:
17191023
19.

Thiazolidinediones improve hepatic fibrosis in rats with non-alcoholic steatohepatitis by activating the adenosine monophosphate-activated protein kinase signalling pathway.

Zhang W, Wu R, Zhang F, Xu Y, Liu B, Yang Y, Zhou H, Wang L, Wan K, Xiao X, Zhang X.

Clin Exp Pharmacol Physiol. 2012 Dec;39(12):1026-33. doi: 10.1111/1440-1681.12020.

PMID:
23127227
20.

[The role of adiponectin and adiponectin receptor 2 in the pathology of fatty liver].

Li HS, Feng Q, Hu YY, Chen SD, Peng JH, Li XM, Xu LL.

Zhonghua Gan Zang Bing Za Zhi. 2009 Nov;17(11):826-30. Chinese.

PMID:
19958641

Supplemental Content

Support Center